Global Genomics in Cancer Care Market Analysis: Innovations, Growth, and Forecast
Author : Sakshi Jagtap | Published On : 10 Jul 2026
According to a research report published by Spherical Insights and Consulting, the global genomics in cancer care market size was worth around USD 24.28 billion in 2025 and is predicted to grow to around USD 108.05 billion by 2035 with a compound annual growth rate (CAGR) of 16.1% from 2026 to 2035.
The global genomics in cancer care market includes genomic technology, sequencing technology, bioinformatics technology, and molecular diagnostic technology that are used for detecting the presence of any genetic mutation, precision oncology, risk assessment of cancer, monitoring the progress of the disease, and personalization of cancer treatment strategy. The technologies are being extensively used for early diagnosis of cancer, companion diagnostics, selection of targeted therapies, hereditary cancer diagnosis, and treatment response monitoring. Market growth is being fueled due to growing global burden of cancer, increased utilization of precision medicine, widespread adoption of NGS, and genomic research investments made by governments.
This comprehensive market research report provides an in-depth analysis of the Genomics in Cancer Care market, with a focused evaluation of industry developments through 2025. The study delivers detailed insights into current market dynamics, emerging trends, growth drivers, competitive landscape, future strategic outlook, and the evolving regulatory key segments.
The Global Genomics in Cancer Care Market Report identifies emerging business opportunities while supporting informed strategic and tactical decision-making. Designed for stakeholders operating in a highly competitive and rapidly evolving landscape, this study delivers up-to-date market intelligence essential for tracking performance, mitigating risks, and driving sustainable growth and profitability.
List of Key Companies
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd.
- Guardant Health, Inc.
- Thermo Fisher Scientific Inc.
- Foundation Medicine, Inc.
- Agilent Technologies, Inc.
- GE Healthcare
- Abbott
- PerkinElmer
- Myriad Genetics, Inc.
- Beckman Coulter
- QIAGEN N.V.
- Bio-Rad Laboratories, Inc.
- Quest Diagnostics Incorporated
- Others
Our expert team is consistently working on updated data and information on the key player's related business processes that value the market for future strategies and predictions
Get Access to a Free Copy of Our Latest Sample Report - https://www.decisionsadvisors.com/request-sample/SI20131
Market Segmentation:
By Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate & Genitourinary Cancers
- Hematologic/Blood Cancers
- Other Cancers
By Technology
- Next-Generation Sequencing (NGS)
- Whole Genome Sequencing
- Targeted Panels
- Exome Sequencing
- PCR/qPCR Technologies
- Microarrays/Expression Profiling
- Other Genomic Technologies
Key Insights Covered in the Global Genomics in Cancer Care Market Size & Industry Forecast Report (2020–2035):
1. Detailed analysis of the Global Genomics in Cancer Care Market Size, production capacity, utilization rate, output trends, capital investment patterns, and regulatory landscape, along with comprehensive profiles of leading market players.
2. Thorough assessment of Genomics in Cancer Care Market Growth, revenue analysis, historical performance, and forward-looking projections across major regional markets.
3. In-depth Genomics in Cancer Care Industry Analysis covering competitive landscape, company market share, pricing trends, and future opportunity mapping.
4. Strategic evaluation of recent developments including mergers & acquisitions, partnerships, collaborations, joint ventures, geographic expansions, and product launches shaping the Genomics in Cancer Care Market Share.
5. Comprehensive value chain and supply chain analysis highlighting raw material sourcing, distribution channels, and end-user segmentation.
6. Regional regulatory framework assessment and policy impact analysis influencing the Genomics in Cancer Care Industry Forecast across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
7. Coverage of technological advancements, product innovations, R&D investments, automation trends, and digital transformation influencing long-term Global Genomics in Cancer Care Market Growth.
Buy this report now:- https://www.decisionsadvisors.com/checkout/select-licence?report_id=SI20131
Industry Developments:
Regional Analysis for Genomics in Cancer Care Market:
✫ North America: (U.S., Canada, Mexico)
✫ Europe: (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
✫ Asia-Pacific: (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
✫ South America: (Colombia, Brazil, Argentina, Rest of South America)
✫ Middle East & Africa: (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
⏩ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
⏩ Top-down and bottom-up approach for regional analysis
⏩ Porter’s five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
⏩ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Insightful customization inquiry before buying:- https://www.decisionsadvisors.com/request-customization/SI20131
Frequently asked questions:
➥ What is the market size of the Genomics in Cancer Care market?
➥ What is the market growth rate of the Genomics in Cancer Care market?
➥ What are the Genomics in Cancer Care market opportunities and threats faced by the vendors in the global Genomics in Cancer Care Industry?
➥ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➥ What focused approach and constraints are holding the Genomics in Cancer Care market?
➥ What are the different sales, marketing, and distribution channels in the global industry?
Unlock the full report now! @ https://www.sphericalinsights.com/reports/genomics-in-cancer-care-market
About the Decisions Advisors
Decisions Advisors is a comprehensive market research and consulting company that provides actionable insights based on data. We deal with businesses from various industries and deliver a market intelligence, competitive analysis, forecasting, and bespoke consulting. We also conduct bespoke consulting for our clients.
We provides well-supported advice and intelligence on how businesses can operate in a given market and succeed in achieving their goals.
Contact Us:
Company Name: Decision Advisors
Email: [email protected]
Phone: +1 303 800 4326 (US)
